CORDIS LLC (PR)
Manufacturer adverse-event records for CORDIS LLC come from the U.S. Food & Drug Administration (FDA) MAUDE database via openFDA, refreshed March 2026 - see our methodology. Not medical advice.
FDA MAUDE device safety record · 2003–2014 · thin-book · elevated Death-code · injury-heavy
Death-code intensity
CORDIS LLC carries an elevated Death-code share
Death-coded event_type rows are 533 of 5,760 (9.25% · elevated tercile among 443 manufacturers). Absolute volume is thin-book.
What the Death-code reading shows for CORDIS LLC (PR)
The standout signal for CORDIS LLC (PR) is Death-code intensity: 9.25% of 5,760 reports (elevated tercile), while absolute volume is thin-book.
As a thinner-book manufacturer, a handful of device families can swing the totals; open the device table rather than reading the company headline alone. Event_type counts are not the same population as Patient Outcomes.
Reports span 3 device types, led in this extract by Injury at 4,148 (72.0% of event_type total). Peak single-year volume reaches 1,067 reports across 12 years. These are raw FDA submissions, not adjudicated findings. Snapshot . Verify current communications on the FDA MDR page.
Event Types
Patient Outcomes
FDA patient-outcome codes (separate from event_type). Percentages use this chart's row total.
Devices (3)
| Device | Reports |
|---|---|
| Coronary Drug-Eluting Stent | 5,755 |
| Stent, Coronary | 4 |
| Stent, Superficial Femoral Artery, Drug-Eluting | 1 |
Yearly Trend
Read our methodology - how this data is sourced, computed, and verified.